Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests
An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.
Feb 4, 2013